Keith O’Neill

Keith’s career, for more than 20 years, has been focussed on the development and commercialisation of innovative healthcare products and services.

Prior to Novus Diagnostics, Keith was responsible for global innovation alliances for Abbott’s medicines business; partnering to bring innovative health technologies to patients in more than 100 countries around the World.

Keith worked with a diverse portfolio of leading healthcare companies as Head of Lifesciences at Enterprise Ireland; an organisation that invests in innovation in companies from ranging from start-ups to multinationals. He has also held leadership roles at the Biomedical Diagnostics Institute and at the Broad Institute of MIT & Harvard, and sales and marketing roles at Harvard Bioscience and Stratagene.

Keith currently serves as Chair of the commercialisation advisory board of Royal College of Surgeons in Ireland and previously served as advisory board Chair for Knowledge Transfer Ireland, an initiative of the Government of Ireland to accelerate innovation, commercialisation and economic development.